Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Human galectins induce conversion of dermal fibroblasts into myofibroblasts and production of extracellular matrix: potential application in tissue engineering and wound repair

B. Dvořánková, P. Szabo, L. Lacina, P. Gal, J. Uhrova, T. Zima, H. Kaltner, S. André, HJ. Gabius, E. Sykova, K. Smetana

. 2011 ; 194 (6) : 469-480.

Language English Country Switzerland

Document type Journal Article, Research Support, Non-U.S. Gov't

E-resources Online Full text

NLK ProQuest Central from 1999-01-01 to 2015-12-31
Medline Complete (EBSCOhost) from 1999-01-01 to 1 year ago
Health & Medicine (ProQuest) from 1999-01-01 to 2015-12-31

Members of the galectin family of endogenous lectins are potent adhesion/growth-regulatory effectors. Their multifunctionality opens possibilities for their use in bioapplications. We studied whether human galectins induce the conversion of human dermal fibroblasts into myofibroblasts (MFBs) and the production of a bioactive extracellular matrix scaffold is suitable for cell culture. Testing a panel of galectins of all three subgroups, including natural and engineered variants, we detected activity for the proto-type galectin-1 and galectin-7, the chimera-type galectin-3 and the tandem-repeat-type galectin-4. The activity of galectin-1 required the integrity of the carbohydrate recognition domain. It was independent of the presence of TGF-β1, but it yielded an additive effect. The resulting MFBs, relevant, for example, for tumor progression, generated a matrix scaffold rich in fibronectin and galectin-1 that supported keratinocyte culture without feeder cells. Of note, keratinocytes cultured on this substratum presented a stem-like cell phenotype with small size and keratin-19 expression. In vivo in rats, galectin-1 had a positive effect on skin wound closure 21 days after surgery. In conclusion, we describe the differential potential of certain human galectins to induce the conversion of dermal fibroblasts into MFBs and the generation of a bioactive cell culture substratum.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12034950
003      
CZ-PrNML
005      
20160707144512.0
007      
ta
008      
121023s2011 sz f 000 0|eng||
009      
AR
024    7_
$a 10.1159/000324864 $2 doi
035    __
$a (PubMed)21494018
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Dvořánková, Barbora, $u Institute of Anatomy, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Center of Cell Therapy and Tissue Repair, 2nd Faculty of Medicine, Charles University $d 1955- $7 xx0076196
245    10
$a Human galectins induce conversion of dermal fibroblasts into myofibroblasts and production of extracellular matrix: potential application in tissue engineering and wound repair / $c B. Dvořánková, P. Szabo, L. Lacina, P. Gal, J. Uhrova, T. Zima, H. Kaltner, S. André, HJ. Gabius, E. Sykova, K. Smetana
520    9_
$a Members of the galectin family of endogenous lectins are potent adhesion/growth-regulatory effectors. Their multifunctionality opens possibilities for their use in bioapplications. We studied whether human galectins induce the conversion of human dermal fibroblasts into myofibroblasts (MFBs) and the production of a bioactive extracellular matrix scaffold is suitable for cell culture. Testing a panel of galectins of all three subgroups, including natural and engineered variants, we detected activity for the proto-type galectin-1 and galectin-7, the chimera-type galectin-3 and the tandem-repeat-type galectin-4. The activity of galectin-1 required the integrity of the carbohydrate recognition domain. It was independent of the presence of TGF-β1, but it yielded an additive effect. The resulting MFBs, relevant, for example, for tumor progression, generated a matrix scaffold rich in fibronectin and galectin-1 that supported keratinocyte culture without feeder cells. Of note, keratinocytes cultured on this substratum presented a stem-like cell phenotype with small size and keratin-19 expression. In vivo in rats, galectin-1 had a positive effect on skin wound closure 21 days after surgery. In conclusion, we describe the differential potential of certain human galectins to induce the conversion of dermal fibroblasts into MFBs and the generation of a bioactive cell culture substratum.
650    _2
$a zvířata $7 D000818
650    _2
$a extracelulární matrix $x metabolismus $7 D005109
650    _2
$a fibroblasty $x metabolismus $7 D005347
650    _2
$a galektin 1 $x metabolismus $7 D037483
650    _2
$a galektin 3 $x metabolismus $7 D037502
650    _2
$a galektin 4 $x metabolismus $7 D037541
650    _2
$a galektiny $x metabolismus $7 D037161
650    _2
$a lidé $7 D006801
650    _2
$a keratin-19 $x metabolismus $7 D053539
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a myofibroblasty $x metabolismus $7 D058628
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a tkáňové inženýrství $x metody $7 D023822
650    _2
$a transformující růstový faktor beta1 $x metabolismus $7 D053773
650    _2
$a hojení ran $7 D014945
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Szabo, Pavol $7 xx0145899 $u Institute of Anatomy, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Center of Cell Therapy and Tissue Repair, 2nd Faculty of Medicine, Charles University
700    1_
$a Lacina, Lukáš, $d 1979- $7 xx0106429 $u Institute of Anatomy, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Department of Dermatovenerology; Center of Cell Therapy and Tissue Repair, 2nd Faculty of Medicine, Charles University
700    1_
$a Gal, Peter $u Institute of Anatomy, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Department for Biomedical Research, East-Slovak Institute of Cardiovascular Diseases; Department of Pathological Anatomy, University of Veterinary Medicine and Pharmacy, Košice, Slovak Republic
700    1_
$a Uhrová, Jana $7 xx0136255 $u Institute of Clinical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine
700    1_
$a Zima, Tomáš, $d 1966- $7 jn20000620440 $u Institute of Clinical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine
700    1_
$a Kaltner, Herbert $u Institute of Physiological Chemistry, Faculty of Veterinary Medicine, Ludwig-Maximilians-University Munich, Munich, Germany
700    1_
$a André, Sabine $u Institute of Physiological Chemistry, Faculty of Veterinary Medicine, Ludwig-Maximilians-University Munich, Munich, Germany $7 gn_A_00006374
700    1_
$a Gabius, Hans-Joachim $u Institute of Physiological Chemistry, Faculty of Veterinary Medicine, Ludwig-Maximilians-University Munich, Munich, Germany
700    1_
$a Syková, Eva, $d 1944- $7 jn20000710633 $u Center of Cell Therapy and Tissue Repair, 2nd Faculty of Medicine, Charles University; nstitute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague, Czech Republic
700    1_
$a Smetana, Karel, $d 1958- $7 jn20000710554 $u Institute of Anatomy, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; Center of Cell Therapy and Tissue Repair, 2nd Faculty of Medicine, Charles University
773    0_
$w MED00007828 $t Cells, tissues, organs $x 1422-6421 $g Roč. 194, č. 6 (2011), s. 469-480
856    41
$u https://pubmed.ncbi.nlm.nih.gov/21494018 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20121023 $b ABA008
991    __
$a 20160707144301 $b ABA008
999    __
$a ok $b bmc $g 956960 $s 792447
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2011 $b 194 $c 6 $d 469-480 $i 1422-6421 $m Cells tissues organs $n Cells Tissues Organs $x MED00007828
LZP    __
$b NLK112 $a Pubmed-20121023

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...